UK Antimicrobial Susceptibility Testing Market (2024-2029)
The UK Antimicrobial Susceptibility Testing Market was valued at $206.6 Million in 2024 and projected to reach to $246.5 Million by 2029, representing a compound annual growth rate of CAGR 3.6%. The UK antimicrobial susceptibility testing market is positioned for steady growth through 2029, driven by heightened awareness of antimicrobial resistance and increased investment in diagnostic infrastructure.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
UK Antimicrobial Susceptibility Testing Market Trends and Insights
- The UK market reflects steady demand driven by rising antimicrobial resistance concerns and increased diagnostic testing across NHS laboratories and private healthcare facilities.
- The UK's robust healthcare infrastructure and regulatory framework support adoption of advanced susceptibility testing technologies, positioning the country as a key market within Europe. Growth in the UK market is underpinned by heightened awareness of antibiotic stewardship programs and the need for rapid, accurate pathogen identification.
- The UK's emphasis on infection prevention and control standards continues to drive investment in diagnostic capabilities.
- Between 2024 and 2029, the UK market will benefit from technological innovations in automated testing platforms and integration with laboratory information systems, though growth remains moderate compared to global expansion rates..
Key Market Statistics
- CAGR (2024-2029) CAGR 3.6%
- Market Size, 2024 ~USD 206.6 Million
- Forecast, 2029 ~USD 246.5 Million
- Country UK
UK Antimicrobial Susceptibility Testing Market Overview
Market Valuation :
The UK antimicrobial susceptibility testing market was valued at £206.6 million in 2024, with projections reaching £246.5 million by 2029, representing steady growth in diagnostic capabilities across the nation.
NHS Laboratory Demand :
Increased diagnostic testing across NHS laboratories is driving market expansion, as healthcare providers prioritize antimicrobial resistance detection and appropriate antibiotic stewardship protocols.
Private Healthcare Growth :
Private healthcare facilities in the UK are expanding their antimicrobial susceptibility testing capabilities, contributing to market diversification and improved patient outcomes across both public and private sectors.
Resistance Awareness :
Rising antimicrobial resistance concerns in the UK are compelling healthcare institutions to invest in advanced susceptibility testing technologies, supporting regulatory compliance and clinical decision-making.
UK Antimicrobial Susceptibility Testing Market Dynamics
- NHS modernization initiatives and private sector expansion are creating sustained demand for testing solutions.
- The market's 3.6% CAGR reflects the UK's commitment to combating resistance through enhanced laboratory capabilities and clinical diagnostics.
- Regulatory frameworks and infection control standards continue to support market development, with healthcare providers prioritizing rapid and accurate susceptibility testing to optimize treatment outcomes and reduce healthcare-associated infections..
Related Ecosystem
Healthcare It
- Computed Tomography (CT)
- Machine Learning
- Magnetic Resonance Imaging (MRI)
- Natural Language Processing (NLP)
- Predictive Analytics
- CERNER CORPORATION
- PHILIPS HEALTHCARE
- Oracle Corporation
- GE HealthCare Technologies Inc.
- Siemens healthineers
Medical Devices
- Polymerase Chain Reaction (PCR)
- Magnetic Resonance Imaging (MRI)
- Disposable Autoinjectors
- Pulse Oximeters
- Blood Pressure Monitors
- Medtronic plc
- Abbott Laboratories
- Stryker Corporation
- Becton, Dickinson and Company
- CONMED Corporation
Key Takeaways
- The UK antimicrobial susceptibility testing market is valued at £206.6 million in 2024 and will reach £246.5 million by 2029.
- The UK market grows at a 3.6% CAGR, reflecting steady but moderate expansion driven by antibiotic stewardship initiatives.
- The UK's NHS laboratory network and private diagnostic providers are primary adopters of advanced susceptibility testing technologies.
- Regulatory compliance and infection control standards in the UK support sustained investment in diagnostic testing infrastructure.
Antimicrobial Susceptibility Testing Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2024 |
| Fastest Growing Segment | LAB INSTRUMENTS (Product) |
| Forecast Period | 2024-2029 |
| Growth Rate | CAGR of 5% from 2024 to 2029 |
| Largest Segment | QUALITATIVE METHODS (Method) |
| Market Size Base Year (Billions) | ~USD 4.45 (2024) |
| Revenue Forecast (Billions) | ~USD 5.68 (2029) |
| Segments Covered | Product, Type, Method, Application, End User |
UK Antimicrobial Susceptibility Testing Market Report Segmentation
5 segment dimensions are covered across the global market.
By Product
- Consumables
- Lab Disposables
- Lab Instruments
By Type
- Agar Dilution
- Antibacterial Susceptibility Testing
- Antifungal Susceptibility Testing
- Antiparasitic Susceptibility Testing
- Antiviral Susceptibility Testing
- Automated Ast
- Automated Laboratory Instruments
- Broth Macrodilution
- Culture & Growth Media
- Culture And Growth Media
- Disk Diffusion
- Etest Method
- Genotypic Method
- Mic Strips
- Molecular Diagnostics Systems
- Susceptibility Plates
- Susceptibility Testing Disks
By Method
- Qualitative Methods
- Quantitative Methods
By Application
- Clinical Diagnostics
- Drug Discovery & Development
- Epidemiology
- Other Applications
By End User
- Academic & Research Institutes
- Cros
- Hospitals & Diagnostic Centers
- Pharmaceutical & Biotechnology Companies
Target Audience
- NHS Laboratory Directors : Need market intelligence to optimize diagnostic budgets, evaluate new testing technologies, and align laboratory capabilities with national antimicrobial stewardship initiatives and infection prevention standards.
- Private Diagnostic Providers : Require competitive market data to identify growth opportunities, assess pricing strategies, and understand demand trends across private healthcare facilities and independent laboratory networks in the UK.
- Medical Device Manufacturers : Seek UK-specific market insights to guide product development, regulatory submissions, and go-to-market strategies for antimicrobial susceptibility testing platforms and consumables.
- Healthcare Consultants : Need comprehensive market analysis to advise NHS trusts and private providers on laboratory modernization, technology adoption, and operational efficiency improvements in microbiology testing.
- Investment & Strategy Teams : Require detailed market forecasts and growth drivers to evaluate acquisition targets, assess investment opportunities, and develop strategic plans for healthcare diagnostics companies operating in the UK.
Reasons to Buy this Report
- NHS Strategic Planning : Understand market dynamics specific to NHS laboratory networks and public healthcare procurement patterns to inform investment and partnership decisions across England, Scotland, Wales, and Northern Ireland.
- Competitive Positioning : Gain insights into UK-specific competitive landscape, including major suppliers, technology adoption rates, and market share distribution to benchmark your organization's performance against local competitors.
- Regulatory Compliance : Access detailed information on UK regulatory requirements, NICE guidelines, and quality standards governing antimicrobial susceptibility testing to ensure compliant product development and market entry strategies.
- Growth Opportunity Assessment : Identify high-potential segments within the UK market, including emerging technologies, underserved regions, and private healthcare expansion opportunities to prioritize resource allocation and expansion plans.
- Stakeholder Intelligence : Develop targeted engagement strategies with NHS trusts, private laboratories, and clinical microbiology departments by understanding their specific testing needs, budget cycles, and procurement preferences.
Frequently asked questions
What is the current size of the UK antimicrobial susceptibility testing market?
The UK antimicrobial susceptibility testing market was valued at £206.6 million in 2024.
What is the projected market size for the UK by 2029?
The UK market is forecast to reach £246.5 million by 2029, representing growth from the 2024 baseline.
What is the growth rate of the UK antimicrobial susceptibility testing market?
The UK market is expected to grow at a compound annual growth rate (CAGR) of 3.6% between 2024 and 2029.
Which sectors drive demand for susceptibility testing in the UK?
The UK's NHS laboratories, private diagnostic centers, and hospital microbiology departments are primary drivers of demand for antimicrobial susceptibility testing.
How does the UK market compare to global growth trends?
The UK market grows at 3.6% CAGR, which is slower than the global market CAGR of 5%, reflecting the UK's mature healthcare infrastructure and established diagnostic practices.
RESEARCH METHODOLOGY
In that respect, the research has heavily employed both primary and secondary sources in order to comprehensively study the forces influential in the industry. This methodology comprised market segmentation analysis, industry trends, major players, competitive landscape, key market dynamics, and strategies of key companies.
Secondary Research
The secondary research involves D&B Hoovers, Bloomberg Businessweek, Factiva, white papers, annual reports, company filings, investor presentations, and SEC filings for conducting secondary research in developing a database on major industry participants. Key data with regard to leading players, market segmentation, at a various level, industry trends by segments, significant mergers and acquisitions, and the impact of trends and technological perspectives related to the antimicrobial susceptibility testing market.
Primary Research
Primary research in the report included interviewing a cross-section, both from the demand and supply sides, to capture information qualitatively and quantitatively. Supply side: High-level executives' interviews, such as CEOs, VPs, marketing and sales directors, regional sales managers, and technology and innovation directors were contacted from leading companies and organizations in product therapy markets. On the demand side, research was carried out by discussing with professionals like clinicians, procurement managers, purchase managers, department heads, and experts from hospitals, diagnostic centers, pharmaceutical and biotechnological firms, and research and academic institutes. This was necessary to gain a proper view of the market segmentation, significant players in the market, and key trends and dynamics related to the growth of the market.
A breakdown of the primary respondents is provided below:
*Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
Note: Companies are classified into tiers based on their total revenue. As of 2023, Tier 1 = >USD 1 billion, Tier 2 = < USD 500 million, and Tier 3 = < USD 100 million.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
This research examines the Antimicrobial Susceptibility testing market and revenue share among the market leaders. It made use of a combination of primary and secondary research methods to do so. Primary research involved in-depth interviews with CEOs, directors, and senior marketing executives. Secondary research formed annual and financial reports by major industry players. The market value was determined while following a segment-based strategy, and it used revenue details of leading solution providers for differentiating between sources and services.
Covered segments:
Identify the major companies involved in the world Antimicrobial Susceptibility testing market and document their annual revenues or revenues from their particular product category/business division.
The revenue mapping of these leading competitors, based on 2024 data, captures a good share of the market and is thus extrapolated to estimate the total global value of the Antimicrobial Susceptibility testing market:
Data Triangulation
Based on the methodology, categorical and sub-categories segmentation of the global antimicrobial susceptibility testing market was performed. Further, data triangulation and the segmentation process were undertaken to arrive at an accurate data of different segments for the market. Various analyses involved factors and trends of the demand and supply sides. The integration of detailed top-down and bottom-up approaches offered a holistic overview of the antimicrobial susceptibility testing market
Market Definition
The Antimicrobial Susceptibility Testing market involves the diagnosis and determination of effectiveness against pathogens such as bacteria, fungi, and viruses using antimicrobial agents. It consists of several technologies and methodologies employed for the diagnosis of the susceptibility of microorganisms to a variety of antimicrobial agents through automated systems, molecular diagnostics, and traditional culture-based methods. The main aim of AST is to be able to choose appropriate therapy, enhance patient outcomes, and take against the threat of emerging antimicrobial resistance. The market includes products and services used by clinical laboratories, hospitals, research institutions, and other healthcare facilities.
Stakeholders
- Healthcare institutions (hospitals and clinics)
- Healthcare institutions (hospitals and diagnostic centers)
- Research institutions
- Clinical research organizations
- Academic medical centers and universities
- Reference laboratories
- Accountable Care Organizations (ACOs)
- Research and consulting firms
- Contract research organizations (CROs) and contract manufacturing organizations (CMOs)
- Academic medical centers and universities
- Market research and consulting firms
- Group Purchasing Organizations (GPOs)
- Medical Research Laboratories
- Academic Medical Centers and Universities
Report Objectives
- Define, describe, and project the antimicrobial susceptibility testing (AST) market across various dimensions, including product, type, methods, applications, end users, and regional areas.
- Explore opportunities for stakeholders and provide a detailed analysis of the competitive landscape, highlighting the key players in the market.
- Offer comprehensive insights into the principal factors influencing market growth.
- Analyze micro markets by evaluating individual growth trends, potential, and their contributions to the overall market.
- Monitor and review competitive developments such as new product launches, approvals, agreements, partnerships, expansions, acquisitions, and collaborations in the AST sector.
Get the Full Antimicrobial Susceptibility Testing Market Report
Full forecast, segment splits, and company analysis for all Antimicrobial Susceptibility Testing Market.
- Canada Antimicrobial Susceptibility Testing Market
- US Antimicrobial Susceptibility Testing Market
- Germany Antimicrobial Susceptibility Testing Market
- France Antimicrobial Susceptibility Testing Market
- Italy Antimicrobial Susceptibility Testing Market
- Spain Antimicrobial Susceptibility Testing Market
- Japan Antimicrobial Susceptibility Testing Market
- China Antimicrobial Susceptibility Testing Market
- India Antimicrobial Susceptibility Testing Market
- Australia Antimicrobial Susceptibility Testing Market
- South Korea Antimicrobial Susceptibility Testing Market
- Brazil Antimicrobial Susceptibility Testing Market
- Mexico Antimicrobial Susceptibility Testing Market
- Rest Of Europe Antimicrobial Susceptibility Testing Market
- Rest Of Asia Pacific Antimicrobial Susceptibility Testing Market
- Rest Of Latin America Antimicrobial Susceptibility Testing Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
